Microinvasive breast cancer and the role of sentinel lymph node biopsy
Abstract Whether sentinel lymph node biopsy (SLNB) should be performed in patients with microinvasive breast cancer (MIBC) has been a matter of debate over the last decade. MIBC has a favorable prognosis and while metastasis to the axilla is rare, it can impact treatment recommendations. In this stu...
Main Authors: | Sean M. Hacking, Kara-Lynne Leonard, Dongling Wu, Mara Banks, Theresa Graves, Lijuan Wang, Evgeny Yakirevich, Yihong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-07-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-16521-8 |
Similar Items
-
From Immunohistochemistry to New Digital Ecosystems: A State-of-the-Art Biomarker Review for Precision Breast Cancer Medicine
by: Sean M. Hacking, et al.
Published: (2022-07-01) -
Defining triple‐negative breast cancer with neuroendocrine differentiation (TNBC‐NED)
by: Sean M Hacking, et al.
Published: (2023-07-01) -
Sentinel lymph node biopsy in breast cancer
by: Volkan Genç, et al.
Published: (2008-01-01) -
Will Radiomics Replace Sentinel Lymph Node Biopsy?
by: Abdullah S. Eldaly, et al.
Published: (2022-04-01) -
Sentinel lymph node biopsy in breast neoplasms
by: Višnjić Milan, et al.
Published: (2009-01-01)